Literature DB >> 15818616

hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer.

Richard Palmqvist1, Anju Zhang, Dawei Xu, Irina Golovleva, Karl-Fredrik Norrback, Astrid Gruber, Ake Oberg, Roger Stenling, Göran Roos.   

Abstract

In a majority of malignant human tumors telomerase activity can be detected, suggesting an immortal phenotype. Expression of the reverse transcriptase subunit, hTERT, in the human telomerase complex is required for telomerase activity. The regulation of hTERT, from gene level to a fully functional protein, is still a poorly understood process. Increased copy number of the hTERT gene has been demonstrated in a significant portion of established cell lines and tumors of different origin but its relevance for telomerase activity levels is unclear. In the present study, we examined the hTERT gene copy number using fluorescence in situ hybridization (FISH) in samples from 64 colorectal carcinomas and an increased copy number (> or = 3 hTERT gene copies/nucleus) was observed in 31 cases (48%). No statistical association existed between hTERT gene copy number and hTERT RNA expression or telomerase activity. However, a significant relationship was found between an increase in hTERT gene copy number and p53 protein accumulation (p = 0.002) and aneuploidy (p = 0.036). Only 4 tumors showed microsatellite instability, 3 of which had a normal hTERT gene copy number. The data indicated that the increased copy number of the hTERT gene in colorectal carcinoma was a result of genomic instability with no obvious consequence for telomerase activity levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818616     DOI: 10.1002/ijc.21020

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.

Authors:  Jiyue Zhu; Yuanjun Zhao; Shuwen Wang
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

2.  Rearrangement of upstream sequences of the hTERT gene during cellular immortalization.

Authors:  Yuanjun Zhao; Shuwen Wang; Evgenya Y Popova; Sergei A Grigoryev; Jiyue Zhu
Journal:  Genes Chromosomes Cancer       Date:  2009-11       Impact factor: 5.006

Review 3.  Telomerase: The Devil Inside.

Authors:  Mukesh Kumar; Andre Lechel; Çagatay Güneş
Journal:  Genes (Basel)       Date:  2016-07-29       Impact factor: 4.096

4.  Normal and Tumour Tissue mRNA Expressions of Telomerase Complex Genes in Several Types of Cancer.

Authors:  Emel Çalışkan Can; M Can Atalay; Ece Miser Salihoğlu; Ülkü Yalçıntaş Arslan; H Bolkan Şimşek; Sevgi Yardım Akaydın
Journal:  Balkan Med J       Date:  2017-04-13       Impact factor: 2.021

Review 5.  Telomeres and Telomerase in the Development of Liver Cancer.

Authors:  Lena In der Stroth; Umesh Tharehalli; Cagatay Günes; André Lechel
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

Review 6.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

7.  TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer.

Authors:  Frédérique Penault-Llorca; Andrei Tchirkov; Mathilde Gay-Bellile; Lauren Véronèse; Patricia Combes; Eleonore Eymard-Pierre; Fabrice Kwiatkowski; Marie-Mélanie Dauplat; Anne Cayre; Maud Privat; Catherine Abrial; Yves-Jean Bignon; Marie-Ange Mouret-Reynier; Philippe Vago
Journal:  Oncotarget       Date:  2017-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.